oncology
Childhood Cancers

Audiological monitoring a challenge in cisplatin-treated children

International researchers are recommending young children on cisplatin get more frequent hearing tests after finding they are at increased risk for drug-induced hearing loss, but a paediatric oncologist cautions this could add practical, emotional and socioeconomic pressures to oncology centres, patients and their families. A Dutch-Canadian study of 368 patients’ 2052 audiological assessments showed children ...

Already a member?

Login to keep reading.


OR
© 2021 the limbic